SCHEMBL2802449

SCHEMBL2802449

Clc1ccccc1C1Cc2cnc(NCc3ccccn3)nc2-c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.44
FGFR2 P21802 2/20 0.42
CDK2 P24941 3/20 0.40
CCNA2 P20248 2/20 0.40
CCNA1 P78396 2/20 0.40
AURKA O14965 1/20 0.40
CSF1R P07333 1/20 0.39
FGFR3 P22607 1/20 0.39
KCNA5 P22460 2/20 0.39
IGF1R P08069 2/20 0.39
PLK1 P53350 2/20 0.39
JAK2 O60674 1/20 0.39
PIM1 P11309 1/20 0.39
SRC P12931 1/20 0.39
CSNK2A2 P19784 1/20 0.39
JAK1 P23458 1/20 0.39
CCNE1 P24864 1/20 0.39
TYK2 P29597 1/20 0.39
FLT4 P35916 1/20 0.39
FLT3 P36888 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805010 0.88 FGFR1 (0.51) FGFR1FGFR2CDK2CCNA2CCNA1
SCHEMBL2807834 0.87 FGFR1 (0.58) FGFR1FGFR2CDK2CCNA2CCNA1
SCHEMBL2804043 0.86 FGFR1 (0.47) FGFR1FGFR2CDK2CCNA2CCNA1
SCHEMBL13126258 0.84 FGFR1 (0.48) FGFR1FGFR2CDK2CCNA2CCNA1
SCHEMBL2804158 0.84 CYP1A2 (0.44) FGFR1FGFR2CDK2CCNA2CCNA1
SCHEMBL2805731 0.82 FGFR1 (0.42) FGFR1FGFR2CSF1RFGFR3PLK1
SCHEMBL2804022 0.82 FGFR1 (0.43) FGFR1FGFR2CSF1RFGFR3IGF1R
SCHEMBL2803106 0.82 MAPK1 (0.46) FGFR1FGFR2CSF1RFGFR3IGF1R
SCHEMBL17057491 0.81 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3SRC
SCHEMBL2802249 0.80 FGFR1 (0.42) FGFR1FGFR2CSF1RFGFR3IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CDK2 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.